Compare MMYT & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MMYT | RLAY |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.1B |
| IPO Year | 2010 | 2020 |
| Metric | MMYT | RLAY |
|---|---|---|
| Price | $60.51 | $19.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $101.00 | $19.50 |
| AVG Volume (30 Days) | 648.5K | ★ 2.0M |
| Earning Date | 05-20-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $16.83 | N/A |
| Revenue Next Year | $17.24 | $324.03 |
| P/E Ratio | $107.67 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $32.67 | $3.44 |
| 52 Week High | $103.56 | $21.27 |
| Indicator | MMYT | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 57.96 | 49.08 |
| Support Level | $53.09 | $18.02 |
| Resistance Level | $60.67 | $20.59 |
| Average True Range (ATR) | 2.17 | 0.90 |
| MACD | -0.22 | -0.08 |
| Stochastic Oscillator | 30.97 | 26.78 |
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.